Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study

OBJECTIVES: The TITAN study is a randomized, double‐blind, placebo‐controlled, multinational trial that evaluated apalutamide with androgen deprivation therapy in patients with metastatic castration‐sensitive prostate cancer. At the first interim analysis in the Japanese subpopulation (median follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Hirotsugu, Arai, Gaku, Uemura, Hiroji, Suzuki, Hiroyoshi, Aoyama, Junya, Hatayama, Tomoyoshi, Ito, Miku, Lefresne, Florence, McCarthy, Sharon, Mundle, Suneel, He, Jin, Chi, Kim N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles: Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310605/
https://www.ncbi.nlm.nih.gov/pubmed/35293030
http://dx.doi.org/10.1111/iju.14843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310605/
https://www.ncbi.nlm.nih.gov/pubmed/35293030
http://dx.doi.org/10.1111/iju.14843

Ejemplares similares